Help yourpatients feel goodinside and out.Sustenex® survives 10x betterthan other probiotics so it gets to whereit needs to be <strong>for</strong> healthy digestion. ‡Sustenex® contains BC 30 (Bacillus coagulans GBI-30, 6086),a unique probiotic with a natural protective layer of proteins whichallows the probiotic to better withstand the stomach’s acidic andhostile gastric environment. Sustenex® offers superior survivabilityversus other probiotics and yogurt so it can reach the digestive tract insignificant number and have the greatest health benefit. ‡Benefits of Sustenex®Proof #ApprovalDelivers 10x better survivability vs. other probiotics and yogurt ‡ColorsCreative DesignerSupports a healthy balance of beneficial bacteria Helps promote a healthy immune system Brand Manager RedAvailable in Capsules, Gummies & Soft Chews!Project Management BlueFor more in<strong>for</strong>mation, visit www.Sustenex.comPackaging Engineer Pink THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE Labeling OR PREVENT Specialist ANY DISEASE. Purple‡ Based on median % survivability of Sustenex® vs. probiotic supplements and 20 probiotic yogurts in simulated© 2012 Scientist Schiff Nutrition Group, Inc. Purplegastric pH <strong>for</strong> 2 hours. Survivability of probiotic cells is one of several factors influencing overall product effect.ResearchRegulatory Affairs683-A1BlackGreenBlack<strong>ADVANCE</strong> <strong>for</strong> <strong>NPs</strong> & <strong>PAs</strong>NO CHA11
Front&CenterOTC MULTIPURPOSEMOISTURE BARRIERTEMPORARILY RELIEVESDISCOMFORT & ITCHINGProtects and Helps HealSkin Irritations from:• Incontinence of Urine orFeces• Diaper Rash• Wound Drainage• Minor Burns, ScrapesCALL1-800-800-3405For morein<strong>for</strong>mationand free sampleswww.calmoseptineointment.comFREE WEBINARSFROM <strong>ADVANCE</strong>FEBRUARY 2012■ Leading a Successful TeamTuesday, February 14 • 1:00 PM - 1:45 PM ETLearn the principles of winning <strong>for</strong>mulas fromproven leaders: Elizabeth Dole, Rudy Giuliani,sales expert Tom Hopkins and Meg Whitman.This webinar will focus on how wisdom,strategic thought and courage intertwine tocreate successful teams. Included will be a brief introduction toleadership benchmarks and the SWOT Analysis.■ About the presenter: Shirley Premont is a consultant andtrainer with SpaceCycles, a cloud solutions and businessconsulting firm based in Redondo Beach, CA.Register now. http://nurse-practitioners-and-physician-assistants.advanceweb.com/Webinar/Editorial-Webinars/Leadinga-Successful-Team.aspxSIGN UP ONLINE FORTHESE FREE EVENTS!www.advanceweb.com/NPPANews <strong>for</strong> <strong>NPs</strong> & <strong>PAs</strong>Maine Working to Curb Opioid AbuseAfter a survey of controlled substance prescribers inMaine reported a high incidence of opioid abuse by stateresidents, a legislative committee voted to move ahead withef<strong>for</strong>ts designed to curb this abuse.The survey was created by a work group <strong>for</strong>med by alegislative initiative titled “Resolve: To Reduce OpioidOverprescription, Overuse and Abuse.” (Find this documentat http://www.mainelegislature.org/legis/bills/bills_125th/billtexts/HP110202.asp.) Bonnie Lundquist, NP, an appointedmember of the work group, said that although the surveywas available to all prescribers, the majority of respondentsto the survey were physicians and <strong>NPs</strong>. Lundquist said themost striking results of the survey include the following:• 90% of prescribers characterize the opioid abuse andaddiction problem in their area as moderate or severe• 80% attempt to identify patients at risk <strong>for</strong> opioid diversionor addiction• 85% try to reduce risk of addiction or diversion by usingpatient education or treatment agreements.The survey also found that most prescribers use precautionarymeasures to avoid abuse, such as urine tests andpill counts. More than 350 respondents wrote comments,many of which indicated frustration with lack of treatmentoptions, the state’s prescription monitoring program,patients and legislation.“The comments were very telling about how huge this problemis and how providers agonize over it,” Lundquist said. Althoughthe response rate was 10% of the state’s controlled substanceprescribers, the survey was not statistically valid becauserespondents were not chosen at random, she explained.“Nevertheless, we do believe the survey is very in<strong>for</strong>mative,”she said. “As a long-term pain management provider, I feelvery strongly both about this topic and about the need <strong>for</strong><strong>NPs</strong> to be at the table when such possible legislative actionis considered.”In January, the Maine Legislature’s Health and HumanServices Committee reviewed the report from the workgroup (http://www.maine.gov/dhhs/osa/pubs/osa/2011/LD1501SASCFinalReport.pdf) and approved the establishmentof a Drug Disposal Task Force to explore ways todispose of expired and unused medications. The committeevoted to continue to review the remaining recommendations.Lundquist is hopeful that the recommendations willbe implemented quickly.“I personally plan to continue following the progressof our report as it goes through state government,” shesaid, “and I am optimistic that I will be appointed to thestanding task <strong>for</strong>ce being established by the governor todeal with this issue.”12 <strong>ADVANCE</strong> <strong>for</strong> <strong>NPs</strong> & <strong>PAs</strong>
Change language